Emergence of Candida albicans fungemia during voriconazole therapy.
Mohammedi
I
I
Medical Intensive Care Unit, Pavilion N, Edouard Herriot Hospital, Place d'Arsonval 69003, Lyon, France. ismael.mohammedi@chu-lyon.fr
Thiebaut
A
A
Piens
M A
MA
Argaud
L
L
Martin
O
O
Robert
D
D
D000328:Adult; D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002176:Candida albicans / Q000187:drug effects*; D002177:Candidiasis / Q000188:drug therapy / Q000382:microbiology; D025141:Drug Resistance, Fungal; D017809:Fatal Outcome; D005260:Female; D016469:Fungemia / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D008826:Microbial Sensitivity Tests; D011743:Pyrimidines / Q000494:pharmacology / Q000627:therapeutic use*; D014230:Triazoles / Q000494:pharmacology / Q000627:therapeutic use*; D065819:Voriconazole
D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole